Similarly, Eli Lilly highlighted on August 8 that progress on supply has bolstered their outlook, but that the end pharmacy experience will continue to be choppy. The FDAs Drug Shortage List The GLP-1 shortage began in March 2022, with semaglutide injection (the active pharmaceutical ingredient in Ozempic and Wegovy) first appearing on the FDAs shortage list , followed by tirzepatide injection (the active pharmaceutical ingredient in Mounjaro and Zepbound) in December 2022
PMCID: PMC8865914
MaKayla Thomas Makayla is a personal trainer & fitness nutrition specialist
fields Lilly, Novo (via the UBT-251 license and an internal NNC program), D&D Pharmatech (DD-03 / DD-15, both linked to Metsera and therefore now Pfizer after the 2025 acquisition), Protagonist, Cascade, and Rani
Maryam S, Ul Haq I, Yahya G, et al
Mike DeWine and the Ohio Department of Medicaid to extend coverage for these evidence-based medications to treat obesity and help prevent the onset of type 2 diabetes